Covered recipient · General Payments record
ISHITA A GAMBHIR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$7,324.46
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $789.48 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merz Pharmaceuticals, LLC | $211.21 | 2 |
| Medtronic, Inc. | $192.19 | 3 |
| ORGANOGENESIS INC. | $122.13 | 1 |
| Amneal Pharmaceuticals LLC | $93.66 | 4 |
| ABBVIE INC. | $91.75 | 4 |
| Lundbeck LLC | $22.44 | 1 |
| Lilly USA, LLC | $19.85 | 1 |
| Kyowa Kirin, Inc. | $19.44 | 1 |
| Acorda Therapeutics, Inc | $16.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.01 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103768318 | CMS |
| ABBVIE INC. | $19.88 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103768320 | CMS |
| ABBVIE INC. | $32.74 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103768322 | CMS |
| ABBVIE INC. | $23.12 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103768324 | CMS |
| Acorda Therapeutics, Inc | $16.81 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142348508 | CMS |
| Amneal Pharmaceuticals LLC | $25.06 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186158 | CMS |
| Amneal Pharmaceuticals LLC | $23.86 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186160 | CMS |
| Amneal Pharmaceuticals LLC | $20.88 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186162 | CMS |
| Amneal Pharmaceuticals LLC | $23.86 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186164 | CMS |
| Kyowa Kirin, Inc. | $19.44 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127031573 | CMS |
| Lilly USA, LLC | $19.85 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012139 | CMS |
| Lundbeck LLC | $22.44 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917109 | CMS |
| Medtronic, Inc. | $29.36 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119370379 | CMS |
| Medtronic, Inc. | $59.30 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119370381 | CMS |
| Medtronic, Inc. | $103.53 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119370383 | CMS |
| Merz Pharmaceuticals, LLC | $25.06 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137949796 | CMS |
| Merz Pharmaceuticals, LLC | $186.15 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137949794 | CMS |
| Organogenesis Inc. | $122.13 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145428370 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.